MORRA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 166
EU - Europa 73
AS - Asia 53
AF - Africa 6
Totale 298
Nazione #
US - Stati Uniti d'America 165
IT - Italia 33
CN - Cina 23
SG - Singapore 16
HK - Hong Kong 12
NL - Olanda 12
DE - Germania 8
CI - Costa d'Avorio 6
FI - Finlandia 5
IE - Irlanda 5
BE - Belgio 3
CZ - Repubblica Ceca 2
GB - Regno Unito 2
IN - India 2
RU - Federazione Russa 2
CA - Canada 1
UA - Ucraina 1
Totale 298
Città #
Chandler 49
Ashburn 16
Singapore 15
Hong Kong 12
Amsterdam 10
Beijing 9
Santa Clara 9
Dearborn 5
Napoli 5
Boston 4
Falls Church 4
Nanjing 4
Naples 4
Seattle 4
Wilmington 4
Des Moines 3
Falkenstein 3
Lawrence 3
Millbury 3
Princeton 3
Brno 2
Helsinki 2
Munich 2
Nanchang 2
Redwood City 2
Waanrode 2
Acerra 1
Bolzano 1
Brussels 1
Changchun 1
Changsha 1
Dallas 1
Dublin 1
Esslingen am Neckar 1
Gragnano 1
Guangzhou 1
Hangzhou 1
Hwang Chow 1
Lissone 1
Milan 1
Norwalk 1
Pune 1
San Mateo 1
Toronto 1
Torre Del Greco 1
Trecase 1
Yueqing 1
Zhongshan 1
Totale 203
Nome #
CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC 67
CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer 60
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs 55
Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors 47
The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells 47
Neuropilin-1 expression associates with poor prognosis in HNSCC and elicits EGFR activation upon CDDP-induced cytotoxic stress 37
Totale 313
Categoria #
all - tutte 1.319
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.319


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 10 1 0 1 2 1
2020/20218 0 0 0 0 2 0 0 1 2 1 2 0
2021/202254 0 4 0 0 1 1 1 5 7 6 18 11
2022/202382 8 13 2 12 10 10 0 6 8 10 3 0
2023/202446 4 8 0 2 2 8 3 12 2 0 5 0
2024/202556 8 4 1 4 7 15 17 0 0 0 0 0
Totale 313